NEOGEN CORP(NEOG)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,080 of 2,879 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
NEOG Stock Analysis & AI Quality Score
AI stock analysis and institutional research for NEOGEN CORP (NEOG), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NEOG at 36.9/100 on a 32-signal composite quality model, placing it at rank #2,080 of 2,879 stocks — the bottom half of the AI-ranked universe. NEOG scores in the top quartile across institutional flow (91.6). Areas of concern include revenue growth (23.6) and earnings quality (30.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 41.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q3 2026), NEOGEN CORP reports quarterly revenue of $211.2M, net income of $-17.0M, free cash flow of $11.1M. Top institutional holders of NEOG by reported 13-F value include BlackRock,, VANGUARD PORTFOLIO MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. NEOG trades on the Nasdaq exchange and files with the SEC under CIK 711377. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NEOG daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NEOGEN CORP directly from SEC EDGAR.
Revenue
Q3 2026
$211.2M
Net Income
Q3 2026
$-17.0M
Free Cash Flow
Q3 2026
$11.1M
Get alerted when NEOG's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for NEOGEN CORP including:
Top Institutional Holders of NEOG
BlackRock, Inc.
$303.0M32,621,005 shVANGUARD PORTFOLIO MANAGEMENT LLC
$119.2M12,832,264 shVANGUARD CAPITAL MANAGEMENT LLC
$88.9M9,565,046 shDIMENSIONAL FUND ADVISORS LP
$84.8M9,132,021 shING GROEP NV
$82.7M8,904,300 shSTATE STREET CORP
$79.8M8,590,344 shMACKENZIE FINANCIAL CORP
$72.5M7,803,226 shNeuberger Berman Group LLC
$72.0M7,751,718 shHudson Bay Capital Management LP
$60.4M6,500,180 shGates Capital Management, Inc.
$58.1M6,258,649 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $303.0M | 32,621,005 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $119.2M | 12,832,264 |
| VANGUARD CAPITAL MANAGEMENT LLC | $88.9M | 9,565,046 |
| DIMENSIONAL FUND ADVISORS LP | $84.8M | 9,132,021 |
| ING GROEP NV | $82.7M | 8,904,300 |
| STATE STREET CORP | $79.8M | 8,590,344 |
| MACKENZIE FINANCIAL CORP | $72.5M | 7,803,226 |
| Neuberger Berman Group LLC | $72.0M | 7,751,718 |
| Hudson Bay Capital Management LP | $60.4M | 6,500,180 |
| Gates Capital Management, Inc. | $58.1M | 6,258,649 |
More Healthcare Companies
View all Healthcare →Put NEOG on your watchlist
Track score changes the day NEOGEN CORP files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is NEOG a good stock to buy?
13F Pro's AI-powered analysis of NEOGEN CORP (NEOG) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NEOG are available on the NEOG stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own NEOG?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NEOG. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of NEOGEN CORP's investment landscape.